Can AtriCure (ATRC) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
AtriCure, Inc. (ATRC), in medical products space, could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ATRC’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that AtriCure could be a solid choice for investors.
Current Quarter Estimates for ATRC
In the past 30 days, 2 estimates have gone higher for AtriCure while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 23 cents a share 30 days ago, to a loss of 21 cents today.
Current Year Estimates for ATRC
Meanwhile, AtriCure’s current year figures are also looking quite promising, with 3 estimates moving higher in the past month, compared to no downward revision. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of 94 cents per share 30 days ago to a loss of 81 cents per share today.
Bottom Line
The stock has also started to move higher lately, adding 8.4% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ATRICURE INC (ATRC): Free Stock Analysis Report
To read this article on Zacks.com click here.
